Novation contracts Amersham for nuclear medicine products

TriMed Staff | | Health Imaging | Practice Management
Amersham Health has received a three-year contract from Novation for its nuclear medicine radiopharmaceutical and related products.

 The pact is effective Jan. 1, 2004 through Dec. 31, 2006.

 The Buckinghamshire, United Kingdom company will provide the group purchasing company with products, such as its Myoview kit for the preparation of Technetium Tc99m and Tetrofosmin injection for myocardial perfusion.

 Novation is the supply company of VHA Inc., based in Irving, Texas, and University HealthSystem Consortium (UHC), which operates from Oakbrook, Ill.

TriMed Staff

Related Content

Do large language models help or hinder workflows related to radiology reports?
Hospital creates 'virtual reality technologist' role to support patients during interventional procedures
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI
Warning: Sidelined reactor could trigger medical isotope shortage
Malpractice watchers: Radiologists, imaging societies should bone up on the ‘science of visual perception’

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.